WMSA
CYTK icon

Weiss Multi-Strategy Advisers’s Cytokinetics CYTK Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,286
Closed -$2.03M – 129
2023
Q4 		$2.03M Sell
24,286
-45,714
-65% -$1.66M 0.05% 369
2023
Q3 		$2.06M Buy
70,000
+778
+1% +$25.9K 0.05% 370
2023
Q2 		$2.26M Buy
69,222
+5,340
+8% +$198K 0.05% 451
2023
Q1 		$2.25M Buy
+63,882
New +$2.61M 0.05% 403
2020
Q4 		– Sell
-10,019
Closed -$217K – 697
2020
Q3 		$217K Buy
+10,019
New +$234K 0.01% 528
2019
Q1 		– Sell
-15,000
Closed -$95K – 532
2018
Q4 		$95K Sell
15,000
-5,095
-25% -$37.4K ﹤0.01% 428
2018
Q3 		$198K Buy
20,095
+95
+0.5% +$762 0.01% 489
2018
Q2 		$166K Sell
20,000
-15,000
-43% -$125K ﹤0.01% 524
2018
Q1 		$252K Sell
35,000
-5,000
-13% -$42.9K 0.01% 496
2017
Q4 		$326K Sell
40,000
-50,000
-56% -$568K 0.01% 519
2017
Q3 		$1.3M Buy
90,000
+4,546
+5% +$62.1K 0.05% 357
2017
Q2 		$1.03M Buy
+85,454
New +$1.19M 0.04% 354
2016
Q3 		– Sell
-13,122
Closed -$125K – 430
2016
Q2 		$125K Sell
13,122
-8,878
-40% -$72.9K 0.01% 388
2016
Q1 		$155K Buy
22,000
+2,000
+10% +$14.6K 0.01% 431
2015
Q4 		$209K Hold
20,000
– – 0.01% 344
2015
Q3 		$134K Hold
20,000
– – 0.01% 374
2015
Q2 		$134K Buy
20,000
+10,000
+100% +$65.6K 0.01% 423
2015
Q1 		$68K Hold
10,000
– – ﹤0.01% 427
2014
Q4 		$80K Buy
+10,000
New +$42.9K ﹤0.01% 394
2014
Q1 		– Sell
-110,000
Closed -$995K – 981
2013
Q4 		$715K Sell
110,000
-831
-0.7% -$5.46K 0.02% 517
2013
Q3 		$839K Sell
110,831
-10,000
-8% -$107K 0.02% 441
2013
Q2 		$1.4M Buy
+120,831
New +$952K 0.04% 354

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CYTK Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 24,286 shares — an estimated $2.03M sold.

Weiss Multi-Strategy Advisers first reported a position in CYTK in Q2 2013 and held it in 22 quarters. The position peaked at $2.26M in Q2 2023. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 24,286 Cytokinetics shares in Q1 2024, an estimated $2.03M.
  • Weiss Multi-Strategy Advisers first reported a position in Cytokinetics in Q2 2013 and held it in 22 quarters.
  • Weiss Multi-Strategy Advisers's Cytokinetics position peaked at $2.26M in Q2 2023.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.